Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.
- DOI
- 10.1016/j.lfs.2020.118423
- Published
- 2020 Nov 1
- Container
- Life sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lfs.2020.118423,
title = {Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.},
author = {Salimifard S and Karoon Kiani F and Sadat Eshaghi F and Izadi S and Shahdadnejad K and Masjedi A and Heydari M and Ahmadi A and Hojjat-Farsangi M and Hassannia H and Mohammadi H and Boroumand-Noughabi S and Keramati MR and Jadidi-Niaragh F},
year = {2020},
journal = {Life sciences},
doi = {10.1016/j.lfs.2020.118423},
url = {https://doi.org/10.1016/j.lfs.2020.118423}
}RIS
TY - JOUR TI - Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression. AU - Salimifard S AU - Karoon Kiani F AU - Sadat Eshaghi F AU - Izadi S AU - Shahdadnejad K AU - Masjedi A AU - Heydari M AU - Ahmadi A AU - Hojjat-Farsangi M AU - Hassannia H AU - Mohammadi H AU - Boroumand-Noughabi S AU - Keramati MR AU - Jadidi-Niaragh F PY - 2020 JO - Life sciences DO - 10.1016/j.lfs.2020.118423 UR - https://doi.org/10.1016/j.lfs.2020.118423 ER -
APA
S, S., F, K. K., F, S. E., S, I., K, S., A, M., M, H., A, A., M, H., H, H., H, M., S, B., MR, K., & F, J. (2020). Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression.. Life sciences. https://doi.org/10.1016/j.lfs.2020.118423
Source records
- pubmed · retrieved 2026-09-25T11:27:04.423Z